U N C O R R E C T E D P R O O F
Ischaemic
Haeme oxygenase (HO) belongs to the heat-shock protein family. It is the rate-limiting enzyme that catalyses the NADPH, O 2 and cytochrome P450 reductase-dependent oxidation of haeme to carbon monoxide (CO), iron and billiverdin. 5 To date, three isoforms of HO have been identified (HO-1, HO-2 and HO-3). HO-1 is a stress-responsive protein induced by various oxidative agents; HO-2 and HO-3 genes are constitutively expressed. 4 Accumulating data have demonstrated a cytoprotective role of HO-1 in various in vivo and in vitro pulmonary disease models, including IR injury. 25, 38 In this study, we hypothesised that IPO may confer protection against lung IR injury and that induction of HO-1 expression may play an essential role in post-conditioningmediated lung protection.
Materials and methods

Animals
The experimental procedures and protocols used in this investigation were approved by the Animal Use Committee at Wuhan University. Specific pathogen-free Sprague-Dawley (SD) rats of either sex, weighing between 190 and 230 g, were housed under constant temperature (23 AE 1 8C) with 12-h light/dark cycles. All rats were fed with water and rodent chows ad libitum.
Surgical procedure and experimental protocol
The animals were anaesthetised with 7% chloral hydrate (5 ml kg À1 , i.p.). A 14-gauge angiocatheter was inserted into the trachea through a midline neck incision. The animals were then connected to a volume-controlled ventilator (DW-2000, Jiapeng Keji, Shanghai, China) with room air at a breath rate of 40 min À1 , a tidal volume of 12 ml kg À1 and a positive end-expiratory pressure of 2 cm H 2 O. The left femoral vein was catheterised and 3:1 crystalloid to colloidal fluid mixture was infused intravenously. The right femoral artery was catheterised for continuous monitoring of mean arterial pressure (MAP) and for blood sampling. A heating pad was applied during anaesthesia in order to keep the body temperature between 36.5 8C and 37.5 8C.
The animals were randomly assigned to one of the four groups. Under aseptic conditions, an in situ unilateral lung warm ischaemia model was used. In brief, a left anterolateral thoracotomy in the fifth intercostal space was made. The left lung was mobilised, the pulmonary hilum was dissected and perivascular and peribronchial tissues were removed. Then, all animals received 500 U kg À1 of heparin intravenously in saline (total volume 500 ml). In group 1 (sham), animals underwent a sham thoracotomy and hilar dissection, but the lungs were not rendered ischaemic. In group 2 (IR), 5 min after heparin administration, the left pulmonary artery, bronchus and pulmonary vein were occluded with a non-crushing microvascular clamp, maintaining the lung in a partially inflated state. Lungs were kept moist with periodic applications of warm, sterile saline, and the incision was covered to minimise evaporative losses. The period of ischaemia was held constant at 40 min, after which the clamp was removed and the lung re-perfused for up to 105 min. In group 3 (IPO), post-conditioning was performed by three successive cycles of 30-s reperfusion per 30-s occlusion, starting immediately after release of the index ischaemia. In group 4 (zinc protoporphyrin IX + IPO group, ZnPPIX + IPO), rats were intra-peritoneally injected with zinc protoporphyrin IX (Sigma, USA), a specific HO-1 inhibitor, at a dose of 20 mg kg
À1
24 h prior to the experiment and the rest of the procedures were similar to that of the IPO group. The rats, which were not administered with any preoperative treatment of ZnPPIX, were injected with an isovolume of normal saline.
Arterial blood gas analysis
Arterial blood sample for blood gas analysis were taken at 20 min of mechanical ventilation (baseline) and 105 min after reperfusion (postoperative). Arterial blood specimens were analysed for PaO 2 and PaCO 2 using blood gas analyser.
Lung wet-to-dry weight ratio
At the end of the experiments, the left lower lobe of the lung was dissected and dried at a constant temperature of 80 8C for 24 h to obtain a dehydrated consistency. The ratio of wet weight to dry weight (W/D) was calculated to assess tissue oedema, as described previously. 36 
Lung histopathological analysis
At the end of the experiments, the left upper lobe of lung was fixed in 10% buffered formalin and 4-mm sections were prepared from paraffin-embedded tissues. The level of histological tissue injury was assessed by haematoxylin-eosin (H&E) staining using light microscopy. For each animal, three random tissue sections (eight fields per section) were examined. The severity of lung injury was graded by an investigator who was initially blinded to research groups, using a four-point scale according to combined assessments of amount of alveolar congestion, haemorrhage, infiltration or aggregation of neutrophils in the airspace or vessel wall, and thickness of alveolar wall/hyaline membrane formation. 29 The following criteria were considered: 0 = no damage, l = mild damage, 2 = moderate damage and 3 = severe damage.
Immunohistochemical staining for HO-1
The expression of HO-1 was determined by immunohistochemistry. After deparaffinisation, endogenous peroxidase was quenched with 0.3% H 2 O 2 in 60% methanol for 30 min. The sections were permeabilised with 0.1% Triton X-100 in phosphate-buffered saline for 20 min. Nonspecific absorption was minimised by incubating the section in 2% normal goat serum in phosphate-buffered saline for 20 min. The sections were then incubated overnight with 1:500 dilution of primary rabbit anti-HO-1 polyclonal antibody (Boster Bio-Tech, Wuhan, China), followed by biotin-conjugated secondary antibody at 1:1000 dilutions. Finally, the sections were incubated with avidin-biotin complex kit (Boster Bio-Tech, Wuhan, China) and detected by using a diaminobenzidine (DAB) reagent (Boster Bio-Tech, Wuhan, China).
The slides were examined in 400-fold magnification by light microscopy (Olympus BX50 microphotographic system, Japan) by an investigator who was blinded to research groups. For each animal, three random tissue sections (eight fields per section) were examined. Quantitative immunohistochemical assessments for lung HO-1 expression were performed as previously described. 36 A mean optical density (OD), which relates to immunohistochemical staining intensity, was measured by image cytometry with HIPAS-2000 image analysis software (Qianli Technical Imaging, Wuhan, China).
Determination of lipid peroxidation
The plasma lipid peroxidation contents were assayed by the measurement of MDA, an end product of fatty-acid peroxidation. At 105 min after reperfusion, plasma was isolated from fresh blood samples by centrifugation at 4000 rpm for 10 min at 4 8C. Plasma MDA content was determined by the thiobarbituric acid reaction using a commercial kit (Jiancheng Biological, Nanjing, China), as 35  36  37  38  39  40  41  42  43  44  45  46  47   48   49   50  51  52  53  54  55   56   57  58  59  60  61  62  63  64  65  66  67  68  69  70  71  72  73  74  75  76  77  78  79  80  81  82  83  84  85  86  87  88  89  90  91  92  93  94  95 U N C O R R E C T E D P R O O F described previously. 18 The OD was measured at 532 nm. The values of MDA level were expressed as nanomoles per millilitre.
Statistical analysis
Parametric data were expressed as means AE S.D. Statistical comparisons within groups were analysed by using paired Student's t-test. Comparisons for multiple groups were analysed by using oneway analysis of variance (ANOVA) followed by the Bonferroni's multiple t-test. Lung injury score was presented as median (range) and analysed with Kruskal-Wallis rank test. P < 0.05 was considered statistically significant.
Results
Changes in haemodynamics and blood gas analysis
All animals were haemodynamically stable during the experimental procedure (data not shown). The effect of IPO on lung function as measured by PaO 2 is shown in Fig. 1A . No group differences in the values of PaO 2 were observed at baseline (P > 0.05). No substantial changes in PaO 2 were observed in the sham group (P > 0.05). At 105 min of reperfusion, PaO 2 significantly decreased in the IR, the IPO and the ZnPPIX + IPO (P < 0.05 or P < 0.001 vs. respective baseline values) groups. However, the IPO group had significantly higher PaO 2 compared with the IR (P < 0.01) and the ZnPPIX + IPO groups (P < 0.01), respectively. There was no significant difference in the value of PaO 2 between the IR group and the ZnPPIX + IPO group (P > 0.05). PaCO 2 level (Fig. 1B) at 105 min of reperfusion was significantly higher in the IR (P < 0.01) and the ZnPPIX + IPO (P < 0.01) groups compared with the sham group, but there was no statistical difference between the IPO group and the sham group (P > 0.05).
Lung wet-to-dry weight ratio
The effects of IR on the lung wet-to-dry weight ratio are illustrated in Fig. 2 . Lungs exposed to IR (group IR) had significantly higher lung wet-to-dry weight ratio compared with the sham group (P < 0.001). IPO significantly prevented the marked increase in wet-to-dry weight ratio in response to exposure to IR (P < 0.001 IPO vs. IR group). However, administration of ZnPPIX prior to the induction of IPO did not alter the tissue wet-to-dry weight ratio levels when compared to the IR group (P > 0.05, ZnPPIX + IPO vs. IR group). The IPO group had significantly lower wet-to-dry weight ratio compared with the IR (P < 0.001) and the ZnPPIX + IPO (P < 0.01) groups, respectively.
Lung histopathological changes
The histopathological changes in the left upper lobe of lung tissues at the end of reperfusion were assessed by standard H&E staining. Representative pictures of lung sections from each group are shown in Fig. 3 . No histological alteration was observed in the lung sections from sham-operated rats (Fig. 3A) . The IR group showed acute lung injury characterised by areas of necrosis, neutrophilic inflammation and intra-alveolar and interstitial oedema (Fig. 3B) . The IPO group revealed markedly reduced neutrophilic inflammation and interstitial oedema with preservation of alveoli compared with the IR group (Fig. 3C) . However, when ZnPPIX, a specific inhibitor of HO-1 activity, was administered prior to IPO, the destruction of lung tissue was more severe and neutrophilic inflammation was higher as compared to the IPO group (Fig. 3D) . The lung injury scores were 2.3(1.0), 8.0(2.3), 5.5(1.6) and 9.9(2.0) in the sham, IR, IPO and ZnPPIX + IPO groups, respectively (Fig. 3E) . The lung injury score in the IR group was higher than that in the sham control group (P < 0.001, IR vs. sham group) and was reduced by IPO (P < 0.05, IPO vs. IR group). The difference in lung injury score between the IR and ZnPPIX + IPO groups was not significant (P > 0.05).
Expression of HO-1 protein in the lungs
As shown in Fig. 4 , a very small amount of HO-1 was detected in alveolar macrophage cells of sham group. Significantly increased expressions of HO-1 protein were observed in group IR (P < 0.001, vs. sham) and group IPO (P < 0.001, vs. sham), respectively. When compared to group IR, group IPO had significant higher expression of HO-1 (P < 0.05). Pre-administration with ZnPPIX almost completely abolished the induction of the expression of HO-1 (P < 0.001, ZnPPIX + IPO vs. IPO group).
MDA level
The production of MDA is an indicator for lipid peroxidation and development of oxidative stress. As shown in Fig. 5, at 
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marked increase in MDA formation in response to exposure to IR (P < 0.001, IPO vs. I/R group). HO-1 inhibitor, ZnPPIX, reversed the reductions of MDA in IPO (P < 0.001, ZnPPIX + IPO vs. IPO group).
Discussion
In the present study, IPO improved pulmonary oxygenation, reduced lung wet-to-dry weight ratio, MDA concentrations and histological damage. The protective effects induced by postconditioning were accompanied by a specific, marked lung expression of HO-1. These protective effects were blocked by an HO-1 inhibitor (ZnPPIX), suggesting that HO-1 mediated the protective effects of lung IPO.
Post-conditioning is a recently described novel approach to attenuate IR injury and may have greater clinical potential than pre-conditioning. The concept of IPO was originally described by Zhao et al., who showed that brief intermittent episodes of myocardial IR performed at the onset of reperfusion, reduced infarct size in the canine heart. 41 In the current study, postconditioned lungs showed only slight damage after a sustained IR 
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injury. IPO was implemented by three cycles of 30-s reperfusion per 30-s re-occlusion by the action of clamping and unclamping of the hilum of the left lung. However, it is unclear whether the number of cycles imposed affects the pulmonary protection effects of post-conditioning. Previous studies in the myocardium, from different species, revealed that post-conditioning lost its protection when it is initiated after 60-90 s of full reperfusion. 13, 24 Therefore, it seems important that the post-conditioning stimulus must be applied immediately upon relief of sustained ischaemia.
Although the protective methods differ in timing and adaptive changes between pre-conditioning and post-conditioning, a number of studies have suggested that both protective manoeuvres share some, but not all, mechanisms. 23, 33 In the studies of pulmonary ischaemic pre-conditioning, receptor-mediated signalling pathways, including bradykinin, 20 adenosine, 37 peroxynitrite 31 as well as ATP-sensitive potassium channels, 7 were found to be involved in the mechanism of lung protection. The protective effect of pulmonary IPO may foster further extensive studies exploring the underling mechanisms.
In this study, we found that the protective effect of lung IPO is mediated, at least in part, by HO-1. IPO attenuated the increase in necrosis, neutrophilic inflammation, and intra-alveolar and interstitial oedema. Lung tissue wet-to-dry weight ratios and blood gas exchanges were affected by IPO in a pattern similar to the changes 246  247  248  249  250  251  252  253  254  255  256  257   258  259  260  261  262  263  264  265  266  267  268 269 The beneficial effects of HO-1 induction have been shown to confer protection against lung injury in a variety of experimental models. Using genetic approaches, previous studies have demonstrated that overexpression of HO-1 can attenuate severe lung injury in mice induced by hyperoxia, lipopolysaccharide and influenza virus infection, and so on. 8, 9, 22 In vitro studies have also
shown that the overexpression of HO-1 in rat foetal lung cells or human lung epithelial cells prevents apoptosis in response to increased oxygen tension. 16 In addition, chemical induction of HO-1 was found to protect the lung against the pulmonary injury. 10, 17 Conversely, inhibition of HO-1 was suggested to be potentially detrimental. Otterbein et al. first demonstrated that pharmacological inhibition of HO-1 activity enhanced the susceptibility of rats to lung injury from endotoxaemia. 21 Fujita et al. showed that HO-1-deficient (Hmox1À/À) mice exhibit lethal ischaemic lung injury. 6 Zhang et al. showed that specific knockdown of HO-1 expression using small-interfering RNA in vitro and in vivo significantly increased anoxia-re-oxygenation-and IR-induced apoptosis, respectively. 39 The findings of the current study have added an insight into the association of HO-1 expression with IPO in the lung. The mechanisms by which HO-1 induces cytoprotection against IR injury of the lung are not completely understood, but appear to involve the protective effects of HO-1 by-products, CO, biliverdin/ bilirubin and free iron. 5 CO is produced via haeme catabolism by HO-1 and plays a protective role in lung injury. At low concentrations, CO can confer anti-apoptotic, anti-inflammatory and vasodilatory effects via activation of intracellular signalling pathways, which include soluble guanylate cyclase and/or p38 mitogen-activated protein kinase. 14, 15, 25 Besides, bilirubin, another end product of haeme catabolism, also contributes to the protective effect of HO-1. Bilirubin has been shown to protect against acute lung injury caused by endotoxaemia. 12, 26 The protective effects of bilirubin in IR injury are due to its antioxidant properties. 27 In addition, cytoprotection by HO-1 is attributable to its augmentation of iron efflux. The HO-dependent release of iron results in the up-regulation of ferritin, which in turn limits the capacity of iron to generate reactive oxygen species (ROS) and ironbased free radicals.
2,32
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